4 Top 20 ASX stocks on the nose today

ASX closes down 0.6%, but these 4 weren't in investor's good books

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) closed down 0.6% today, and much of it was driven by several of our large caps stocks suffering big falls.

Here's our view on four of the top 20 biggest falls…

Santos Ltd (ASX: STO) continues to be buffeted from pillar to post, falling 3.8% today to $8.40. Just yesterday, the oil and gas producer says it had postponed an issue of €500 million hybrid securities and slashed its capex bill, as oil falls below US$70 a barrel. The energy company is in the final stages of completing its Gladstone LNG project, and UBS anaylsts estimate Santos will have US$8.2 billion of debt by the end of next year.

Iron ore miner Rio Tinto Limited (ASX: RIO) fell 3.5% to $57.14, despite iron ore prices rising 3% to US$71.25 per tonne overnight. While Rio has been touted as one of the lowest cost iron ore producers on the planet, falling commodity prices will still have an impact on the miner's earnings. And CEO Sam Walsh has ruled out any major mergers or acquisitions, when speaking to investors in London. Rio is under a takeover cloud, with Glencore expected to lob a second bid for the miner next year.

Woodside Petroleum Limited (ASX: WPL) fell 2% to $35.71. Unlike other oil and gas producers, Woodside's shares have only dropped 10% in the past month – Santos shares are down 30%, as the chart below shows. Interestingly, Australia's largest independent oil and gas producer now sports a fully franked dividend yield of 6.5%. Grossed up, that equates to 9.3% dividend yield – putting term deposit rates of 3% to shame.

4 ASX stocks on the nose Dec 2014

Source: Google Finance

CSL Limited (ASX: CSL) the blood plasma company saw its shares drop 1.7% to $85.97. Shares in CSL recently hit a 12-month high, as the company pushes for approval of a new haemophilia drug, which could deliver hundreds of million in sales. A product launch could take place in late 2015 or early 2016 according to the company's chief scientist Andrew Cuthbertson. Today's fall may just be some investors taking some profits given CSL's strong run this year.

Motley Fool writer/analyst Mike King owns shares in Santos and CSL. You can follow Mike on Twitter @TMFKinga

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »